title: Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies.
authors.forename: Soumya D
authors.initials: SD
authors.lastname: Chakravarty
authors.forename: Arthur F
authors.initials: AF
authors.lastname: Yee
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Paget
mesh_terms: D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000276:immunology*; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000628:therapy*; D001491:Basophils / Q000276:immunology* / Q000378:metabolism*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008214:Lymphocytes / Q000145:classification*; D008297:Male; D008407:Mast Cells / Q000276:immunology*; D010727:Phosphoric Diester Hydrolases / Q000096:biosynthesis*; D011755:Pyrophosphatases / Q000096:biosynthesis*; D044967:Serum / Q000276:immunology*; D012867:Skin / Q000276:immunology*; D015854:Up-Regulation / Q000276:immunology*; D014581:Urticaria / Q000188:drug therapy* / Q000276:immunology* / Q000628:therapy*
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D001324:Autoantigens; D007155:Immunologic Factors; D010727:Phosphoric Diester Hydrolases; D011755:Pyrophosphatases